J Donald Easton Selected Research

J Donald Easton Research Topics

Disease

51	Stroke (Strokes) 03/2022 - 11/2002
30	Ischemic Stroke 03/2022 - 01/2003
26	Transient Ischemic Attack 03/2022 - 09/2004
24	Hemorrhage 01/2021 - 11/2008
12	Embolic Stroke 01/2022 - 08/2011
12	Atrial Fibrillation 09/2020 - 06/2006
10	Myocardial Infarction 01/2018 - 01/2003
8	Vascular Diseases (Vascular Disease) 01/2018 - 06/2004
5	Embolism (Embolus) 09/2020 - 03/2010
4	Brain Ischemia (Cerebral Ischemia) 01/2018 - 03/2002
4	Peripheral Arterial Disease 02/2011 - 09/2005
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 07/2016
3	Thrombosis (Thrombus) 04/2014 - 09/2005
2	Infarction (Infarctions) 03/2022 - 06/2009
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 01/2019
2	Ischemia 01/2020 - 06/2009
2	Cerebral Hemorrhage 10/2018 - 10/2003
2	Hemorrhagic Stroke 09/2017 - 09/2011
2	Pathologic Constriction (Stenosis) 04/2017 - 01/2017
2	Atherosclerosis 01/2017 - 01/2003
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 06/2009 - 03/2008
2	Intracranial Sinus Thrombosis (Sinus Thrombosis) 06/2008 - 09/2004
1	Patent Foramen Ovale 01/2021
1	Brain Infarction 09/2017
1	Atrial Flutter (Flutter, Atrial) 06/2012
1	Lacunar Stroke 08/2011
1	Weight Loss (Weight Reduction) 08/2010
1	Obesity 08/2010
1	Hypercholesterolemia 10/2008
1	Hypertension (High Blood Pressure) 03/2008
1	Heart Failure 03/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2008
1	Acute Coronary Syndrome 05/2007
1	Coronary Disease (Coronary Heart Disease) 06/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2006
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2003
1	Unstable Angina 01/2003

Drug/Important Bio-Agent (IBA)

48	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2022 - 11/2002
23	Clopidogrel (Plavix)FDA Link 03/2022 - 11/2002
11	TicagrelorIBA 12/2020 - 12/2015
9	Dabigatran FDA Link 01/2022 - 03/2012
9	apixabanIBA 09/2020 - 03/2010
8	Warfarin (Coumadin)FDA LinkGeneric 09/2020 - 03/2010
7	AnticoagulantsIBA 01/2021 - 09/2004
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 01/2003
6	Thrombin FDA Link 01/2022 - 12/2015
4	Vitamin K FDA Link 09/2020 - 03/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 06/2006
3	Factor Xa InhibitorsIBA 04/2014 - 03/2010
3	Heparin (Liquaemin)FDA LinkGeneric 06/2008 - 03/2002
3	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2008 - 10/2003
3	Dipyridamole (Persantine)FDA LinkGeneric 06/2008 - 09/2004
3	Glycoproteins (Glycoprotein)IBA 03/2008 - 06/2006
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2017 - 08/2010
2	tetrachloroisophthalonitrile (Bravo)IBA 11/2008 - 06/2006
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2008 - 09/2004
2	Purinergic P2Y Receptor AntagonistsIBA 09/2005 - 01/2003
1	CreatinineIBA 01/2022
1	N(4)-oleylcytosine arabinosideIBA 09/2020
1	Cytochrome P-450 CYP2C19IBA 01/2020
1	Cilostazol (Pletal)FDA LinkGeneric 01/2019
1	RivaroxabanIBA 01/2019
1	Phenprocoumon (Liquamar)FDA Link 10/2018
1	Blood Glucose (Blood Sugar)IBA 08/2010
1	EndocannabinoidsIBA 08/2010
1	Triglycerides (Triacylglycerol)IBA 08/2010
1	HDL CholesterolIBA 08/2010
1	RimonabantIBA 08/2010
1	cyclo(Arg-Pro) (CI 4)IBA 08/2010
1	Retinaldehyde (Retinal)IBA 06/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2008
1	ThromboxanesIBA 10/2008
1	2,5-dichloro-4-bromophenol (B 2)IBA 10/2008
1	sibrafibanIBA 06/2006
1	Glucose (Dextrose)FDA LinkGeneric 10/2003
1	antineoplaston A10 (A 10)IBA 01/2003

Therapy/Procedure

27	Therapeutics 12/2021 - 01/2003
4	Secondary Prevention 12/2019 - 04/2014
2	Contraindications 10/2012 - 03/2012
2	Thrombolytic Therapy 06/2008 - 09/2004
1	Anesthesia 06/2009
1	Percutaneous Coronary Intervention 03/2008